Filing Details
- Accession Number:
- 0001181431-13-031139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-29 12:19:43
- Reporting Period:
- 2013-05-24
- Filing Date:
- 2013-05-29
- Accepted Time:
- 2013-05-29 12:19:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1248144 | Adrian Adams | C/O Auxilium Pharmaceuticals, Inc. 640 Lee Road Chesterbrook PA 197087 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-24 | 25,000 | $7.78 | 25,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-05-28 | 50,000 | $8.39 | 75,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide AcelRx Pharmaceuticals, Inc. any security holder of AcelRx Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price.
- The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide AcelRx Pharmaceuticals, Inc. any security holder of AcelRx Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price.
Billionaire Hedge Funds
